Ocugen Stock Up on Development Pact for Covid Vaccine Candidate

Thestreet2021-10-05

Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate. In a Securities and Exchange ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

haoren
2021-10-06
haoren
Nice
- Swifty:
  👍🏻
koolgal
2021-10-06
koolgal
Macula Degeneration is getting more prevalent in the elderly and any aid to alleviate or possibly cure it would be greatly welcomed. So if Ocugen is successful in this respect, it is in for bumper profits ahead! 👍😊
- 滚股怪:
  Good
- Ti82:
  Yeah
- koolgal:
  Thanks 👍😊
- koolgal:
  Thanks 👍😊
ccmk
2021-10-06
ccmk
Wows..
- 1521yes:
  ok
- haoren:
  ok
larkygal
2021-10-06
larkygal
Ya
stormlee
2021-10-06
stormlee
😋😘😉😊😋😉😋👌👌😋👌😋👌😍😀😍
- DesmondAn:
  nice
Qwer1234
2021-10-05
Qwer1234
Ok

发表看法

136

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1173343014?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-05 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173343014","market":"us","top_or_hot":-1,"title":"Ocugen Stock Up on Development Pact for Covid Vaccine Candidate","media":"Thestreet","content":"<div>\n<p>Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.\nIn a Securities and Exchange ...</p>\n\n<a href=\"https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen Stock Up on Development Pact for Covid Vaccine Candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen Stock Up on Development Pact for Covid Vaccine Candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 22:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.\nIn a Securities and Exchange ...</p>\n\n<a href=\"https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal","article_id":"1173343014","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173343014","pubTimestamp":1633444442,"sourceInfo":null,"weMediaInfo":null,"summary":"Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreemen","collect":0,"end_time":0,"defaultTopTitle":"thestreet.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"Ocugen储备Covid候选疫苗开发协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.\nIn a Securities and Exchange Commission 8K filing, Ocugen said Bharat will supply it with clinical-trial materials and, if the drug is cleared by regulators, commercial supplies of finished drug product and drug components.\nShares of Ocugen, Malvern, Pa., at last check were 7% higher at $7.22. Bharat is the Hyderabad, India, biotechnology company.\nOcugen also said in the SEC filing that it entered an amended accord with development partner CanSino Biologics. The agreement is tied to Ocugen's gene-therapy candidate, OCU410, to treat dry age-related macular degeneration.\nUnder the amended accord, the companies will collaborate to develop OCU410. CanSino, the Tianjin, China, vaccine producer, will be responsible for the chemistry, manufacturing and controls of the clinical supplies.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":829306882,"gmtCreate":1633471432491,"gmtModify":1633471432910,"author":{"id":"3581803494981906","authorId":"3581803494981906","name":"haoren","avatar":"https://static.tigerbbs.com/959cadb42575ede705b330aa58d68a63","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3581803494981906","idStr":"3581803494981906"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829306882","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6105122,"gmtCreate":1633480197835,"gmtModify":1634720909666,"authorId":3573686260747225,"author":{"id":3573686260747225,"idStr":"3573686260747225","authorId":3573686260747225,"name":"Swifty","avatar":"https://static.tigerbbs.com/25bc2f32857ae0c620f1d9eee6447454","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829306882,"type":1,"supId":0,"prevId":0,"content":"👍🏻","text":"👍🏻","html":"👍🏻"}],"langContent":"CN"},{"id":829978348,"gmtCreate":1633469306989,"gmtModify":1633469306989,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3559581955535845","idStr":"3559581955535845"},"htmlText":"Macula Degeneration is getting more prevalent in the elderly and any aid to alleviate or possibly cure it would be greatly welcomed. So if Ocugen is successful in this respect, it is in for bumper profits ahead! 👍😊","listText":"Macula Degeneration is getting more prevalent in the elderly and any aid to alleviate or possibly cure it would be greatly welcomed. So if Ocugen is successful in this respect, it is in for bumper profits ahead! 👍😊","text":"Macula Degeneration is getting more prevalent in the elderly and any aid to alleviate or possibly cure it would be greatly welcomed. So if Ocugen is successful in this respect, it is in for bumper profits ahead! 👍😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":18,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/829978348","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6103118,"gmtCreate":1633471123469,"gmtModify":1634721100268,"authorId":4091089381144950,"author":{"id":4091089381144950,"idStr":"4091089381144950","authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829978348,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":6103345,"gmtCreate":1633473364949,"gmtModify":1634721079868,"authorId":3581545771843484,"author":{"id":3581545771843484,"idStr":"3581545771843484","authorId":3581545771843484,"name":"Ti82","avatar":"https://static.tigerbbs.com/9dcf97e9c0724dd0190ad03354b136c5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829978348,"type":1,"supId":0,"prevId":0,"content":"Yeah","text":"Yeah","html":"Yeah"},{"id":6103371,"gmtCreate":1633473492422,"gmtModify":1633473492422,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829978348,"type":1,"supId":6103345,"prevId":0,"content":"Thanks 👍😊","text":"Thanks 👍😊","html":"Thanks 👍😊"},{"id":6103351,"gmtCreate":1633473398240,"gmtModify":1633473398240,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829978348,"type":1,"supId":6103118,"prevId":0,"content":"Thanks 👍😊","text":"Thanks 👍😊","html":"Thanks 👍😊"}],"langContent":"CN"},{"id":829943411,"gmtCreate":1633466512192,"gmtModify":1633466512500,"author":{"id":"3575640395742421","authorId":"3575640395742421","name":"ccmk","avatar":"https://static.tigerbbs.com/a90d67ad1fb38a136eae07512ce11d0f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3575640395742421","idStr":"3575640395742421"},"htmlText":"Wows..&nbsp;","listText":"Wows..&nbsp;","text":"Wows..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829943411","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6102848,"gmtCreate":1633468350947,"gmtModify":1634721125829,"authorId":3575273204402761,"author":{"id":3575273204402761,"idStr":"3575273204402761","authorId":3575273204402761,"name":"1521yes","avatar":"https://static.tigerbbs.com/5c7c5c91dad8a3479b64a59aca3d3845","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829943411,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":6103143,"gmtCreate":1633471415996,"gmtModify":1634721097863,"authorId":3581803494981906,"author":{"id":3581803494981906,"idStr":"3581803494981906","authorId":3581803494981906,"name":"haoren","avatar":"https://static.tigerbbs.com/959cadb42575ede705b330aa58d68a63","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829943411,"type":1,"supId":6102848,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":829923041,"gmtCreate":1633455056650,"gmtModify":1633455057095,"author":{"id":"3582209513703529","authorId":"3582209513703529","name":"larkygal","avatar":"https://static.tigerbbs.com/a22c89190974fdfaf13f46ff41a8c983","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3582209513703529","idStr":"3582209513703529"},"htmlText":"Ya","listText":"Ya","text":"Ya","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829923041","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":829913716,"gmtCreate":1633449669056,"gmtModify":1633449670869,"author":{"id":"3571959390768435","authorId":"3571959390768435","name":"stormlee","avatar":"https://static.tigerbbs.com/80629ef9648273c0d6465aee66dbd98a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571959390768435","idStr":"3571959390768435"},"htmlText":"😋😘😉😊😋😉😋👌👌😋👌😋👌😍😀😍","listText":"😋😘😉😊😋😉😋👌👌😋👌😋👌😍😀😍","text":"😋😘😉😊😋😉😋👌👌😋👌😋👌😍😀😍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829913716","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6102128,"gmtCreate":1633449826054,"gmtModify":1634721174266,"authorId":3581728985872006,"author":{"id":3581728985872006,"idStr":"3581728985872006","authorId":3581728985872006,"name":"DesmondAn","avatar":"https://static.tigerbbs.com/9ac9e35f00f5ca8ebeca124189b27c86","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":829913716,"type":1,"supId":0,"prevId":0,"content":"nice","text":"nice","html":"nice"}],"langContent":"CN"},{"id":829938896,"gmtCreate":1633448862376,"gmtModify":1633448913870,"author":{"id":"3572867061700089","authorId":"3572867061700089","name":"Qwer1234","avatar":"https://static.tigerbbs.com/4f048323098795168028c3aee02d87a4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3572867061700089","idStr":"3572867061700089"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829938896","repostId":1173343014,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":136,"commentSize":11,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173343014"}